We are live on
!
Find out more
NC
Northern Cross Portfolio holdings
AUM
$279M
1-Year Est. Return
1.98%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
-1.98%
3 Year Est. Return
+89.18%
5 Year Est. Return
+0.81%
10 Year Est. Return
–
AUM
$7.37B
AUM Growth
+$612M
(+9.1%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
97.1%
Holding
15
New
1
Increased
2
Reduced
11
Closed
1
Avg Time Held
5.7
quarters
Top 10 Avg Time Held
6.2
quarters
Top 20 Avg Time Held
5.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$533M |
| 2 |
Televisa
TV
|
+$186M |
| 3 |
Grupo Aval
AVAL
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wynn Resorts
WYNN
|
+$184M |
| 2 |
Alibaba
BABA
|
+$174M |
| 3 |
SLB Ltd
SLB
|
+$161M |
| 4 |
Freeport-McMoran
FCX
|
+$138M |
| 5 |
Las Vegas Sands
LVS
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 53.39% |
| 2 | Energy | 17.25% |
| 3 | Financials | 9.22% |
| 4 | Healthcare | 6.8% |
| 5 | Miscellaneous | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Las Vegas Sands
LVS
$23.3B
| $2.13B | 28.93% |
37,354,716
-1,647,804
| -4% | -$89.7M |
2014 Q4
9 quarters
|
|
|
2
SLB Ltd
SLB
$72.5B
| $1.27B | 17.25% |
16,276,609
-1,968,931
| -11% | -$161M |
2015 Q2
7 quarters
|
|
|
3
Wynn Resorts
WYNN
$7.63B
| $1.05B | 14.23% |
9,146,761
-1,844,044
| -17% | -$184M |
2015 Q2
7 quarters
|
|
|
4
Alibaba
BABA
$273B
| $754M | 10.23% |
6,992,874
-1,709,682
| -20% | -$174M |
2015 Q2
7 quarters
|
|
5
Grupo Cibest SA
CIB
$22.4B
| $552M | 7.49% |
13,843,848
-81,459
| -0.6% | -$3.1M |
2014 Q4
9 quarters
|
|
|
6
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $501M | 6.8% |
+15,611,407
| New | +$533M |
2017 Q1
0 quarters
|
|
|
7
Televisa
TV
$1.18B
| $286M | 3.89% |
11,040,583
+7,842,995
| +245% | +$186M |
2016 Q4
1 quarter
|
|
8
Barrick Mining
B
$67.2B
| $161M | 2.19% |
8,497,826
-1,688,992
| -17% | -$31.2M |
2013 Q2
15 quarters
|
|
|
9
Grupo Aval
AVAL
$5.96B
| $128M | 1.73% |
15,614,544
+5,429,802
| +53% | +$43.8M |
2015 Q2
7 quarters
|
|
10
Ambev
ABEV
$49.5B
| $54.3M | 0.74% |
9,431,149
-385,614
| -4% | -$2.12M |
2016 Q1
4 quarters
|
|
|
11
Freeport-McMoran
FCX
$106B
| – | – |
-10,496,295
| Closed | -$138M | – |
|
Similar funds
CG
AAM
CA
KSA
LFR
SH
CT
SCM
Northern Cross's Q1 2017 Portfolio in Review
As of Q1 2017, Northern Cross held 15 positions worth $7.37B, up 9.1% from $6.76B the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Northern Cross's Q1 2017 filing shows 1 new, 2 increased, 11 reduced and 1 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 15,611,407 shares worth $501M. The largest sale was Wynn Resorts, an estimated $184M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, down from 56% a quarter earlier, followed by Energy and Financials.
- Northern Cross's largest Q1 2017 buy was Teva Pharmaceutical Industries Limited: 15,611,407 shares worth $501M.
- Northern Cross added most to Televisa in Q1 2017, an estimated $186M increase.
- Northern Cross's biggest Q1 2017 reduction was Wynn Resorts, cutting an estimated $184M.
- Northern Cross fully exited Freeport-McMoran in Q1 2017, selling an estimated $138M.
- Northern Cross's ten largest holdings make up 97% of its $7.37B portfolio in Q1 2017.
- Northern Cross opened 1 new position and closed 1 in Q1 2017.
- Northern Cross's portfolio value rose 9.1% quarter-over-quarter to $7.37B.
Based on Northern Cross's 13F filing for Q1 2017, filed 15 May 2017.